Opaleye Management Inc. - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 106 filers reported holding MEI PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of MEI PHARMA INC
ValueSharesWeighting
Q4 2021$3,511,000
-18.7%
1,315,000
-16.0%
0.74%
-7.7%
Q3 2021$4,319,000
-3.2%
1,565,0000.0%0.81%
+8.9%
Q2 2021$4,460,000
-16.4%
1,565,000
+0.6%
0.74%
-5.5%
Q1 2021$5,337,000
+29.9%
1,556,0000.0%0.78%
+46.0%
Q4 2020$4,108,000
-15.4%
1,556,0000.0%0.54%
-43.5%
Q3 2020$4,855,000
-24.4%
1,556,0000.0%0.95%
-26.8%
Q2 2020$6,426,0001,556,0001.30%
Other shareholders
MEI PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 3,039,038$9,482,0007.48%
Asymmetry Capital Management, L.P. 787,359$2,457,0001.58%
First Light Asset Management, LLC 3,763,804$11,743,0001.20%
NEA Management Company, LLC 8,533,072$26,623,0001.13%
Opaleye Management Inc. 1,556,000$4,855,0000.95%
BVF INC/IL 4,080,162$12,730,0000.69%
DAFNA Capital Management LLC 666,000$2,078,0000.68%
CAXTON CORP 175,560$548,0000.52%
Alambic Investment Management, L.P. 12,500$39,0000.43%
Boxer Capital, LLC 2,913,091$9,089,0000.31%
View complete list of MEI PHARMA INC shareholders